Quarterly ResultMay 6, 2026, 01:08 PM
LivaNova Q1 Net Income $22.3M, EPS $0.41; Revenue $362.3M
AI Summary
LivaNova PLC reported a net income of $22.29 million for Q1 2026, a significant improvement from a net loss of $327.32 million in Q1 2025, primarily due to the absence of a large SNIA environmental liability expense. Revenue increased to $362.26 million from $316.86 million year-over-year. The company also made an early repayment of $95.9 million on its Term Facilities and achieved a key regulatory milestone for its ImThera acquisition.
Key Highlights
- Net income of $22.29 million, reversing Q1 2025 loss of $327.32 million.
- Basic EPS of $0.41, up from a loss of $6.01 in Q1 2025.
- Net revenue increased to $362.26 million from $316.86 million year-over-year.
- Repaid $95.9 million of Term Facilities debt early in January 2026.
- Achieved ImThera regulatory milestone (FDA PMA) in March 2026.
- SNIA environmental liability expense was $0, compared to $360.39 million in Q1 2025.
- R&D expenses rose to $58.70 million from $37.88 million in Q1 2025.
Price Impact
More from LIVN